Education
About Us
Working with TipRanks
Follow Us
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
Rap-219
Epilepsy, Focal Onset Seizure, Focal Epilepsy, Focal Seizure, Refractory Focal Epilepsy, Seizure
Phase II
Not Yet Recruiting
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Oct 08, 2025
―
Rap-219
Bipolar 1 Disorder
Phase II
Recruiting
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
May 30, 2025
―
Rap-219
Focal Onset Seizures
Phase II
Active Not Recruiting
Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy
Apr 17, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Rapport Therapeutics, Inc. (RAPP) have in its pipeline
RAPP is currently developing the following drugs: Rap-219, Rap-219, Rap-219. These drug candidates are in various stages of clinical development as the company works toward FDA approval.